Clinical Trials Browser

Phase 3 × Has announcements × Carcinoma, Transitional Cell × Clear all

NCT05243550 2024-11-04

ENVISION

Phase 3 Active not recruiting

240 enrolled 20 charts 1 FDA

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02603432 2024-03-27

JAVELIN Bladder 100

Phase 3 Completed

700 enrolled 35 charts 2 FDA

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT02793128 2020-12-22

Olympus

Phase 3 Completed

71 enrolled 16 charts 2 FDA

Carcinoma, Carcinoma, Transitional Cell